
By SHEILA KAPLAN from NYT Health https://ift.tt/31G95SH


Earlier this week, preliminary results from two trials in Congo suggested that the two drugs significantly reduced the risk of death from Ebola.
All of the women who received the vaccine produced antibodies to chlamydia, but one of the vaccines, called CTH522:CAF01, produced nearly six times more antibodies than the other vaccine, the investigators found.